FDA Accepts Supplemental NDA for Percodan by Endo Operations
The FDA has accepted a supplemental NDA for Percodan, which contains aspirin and oxycodone hydrochloride.
Asset / Drug
Drug and asset intelligence for Percodan with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
June 26, 2026 · N/A
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.